Literature DB >> 11276389

The metabolic syndrome and related cardiovascular risk.

F Ramos1, H P Baglivo, A J Ramírez, R Sánchez.   

Abstract

The metabolic syndrome is a complex association of several risk factors including insulin resistance, dyslipidemia, and essential hypertension. Insulin resistance has been associated with sympathetic activation and endothelial dysfunction, which are the main mechanisms involved in the pathophysiology of hypertension and its related cardiovascular risk. According to the Sixth Report of the Joint National Committee, and guidelines of the World Health Organization/International Society of Hypertension, the presence of multiple risk markers suggests that both hypertension and risk factors should be aggressively managed in order to obtain a better outcome. Primary prevention of obesity at different levels--individual, familial, and social-- starting early in childhood has proven to be cost effective, and will be mandatory to reduce the world epidemic of obesity and its severe consequences.

Entities:  

Mesh:

Year:  2001        PMID: 11276389     DOI: 10.1007/s11906-001-0020-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  67 in total

1.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

Review 2.  Obesity and hypertension.

Authors:  N Mikhail; M S Golub; M L Tuck
Journal:  Prog Cardiovasc Dis       Date:  1999 Jul-Aug       Impact factor: 8.194

Review 3.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

Review 4.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 5.  Insulin and the vasculature.

Authors:  N Mikhail; M L Tuck
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 6.  Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.

Authors:  M D Johnson; L K Campbell; R K Campbell
Journal:  Ann Pharmacother       Date:  1998-03       Impact factor: 3.154

7.  Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.

Authors:  G Targher; M Alberiche; M B Zenere; R C Bonadonna; M Muggeo; E Bonora
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid.

Authors:  S Jacob; E J Henriksen; A L Schiemann; I Simon; D E Clancy; H J Tritschler; W I Jung; H J Augustin; G J Dietze
Journal:  Arzneimittelforschung       Date:  1995-08

9.  Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects.

Authors:  Y Harano; A Kageyama; J Hirose; Y Asakura; T Yokota; M Ikebuchi; M Suzuki; T Omae
Journal:  Metabolism       Date:  1995-03       Impact factor: 8.694

Review 10.  Alcohol and the NIDDM patient.

Authors:  D S Bell
Journal:  Diabetes Care       Date:  1996-05       Impact factor: 19.112

View more
  3 in total

Review 1.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Residual urinary output in high body mass index individuals on chronic hemodialysis: A disregarded life vest?

Authors:  Hernán Trimarchi; María S Raña; Alejandra Karl; José Andrews; Mariana Dicugno; Vanesa Pomeranz; Pablo Young; Mariano Forrester; Mirta Alonso; Fernando Lombi; Alexis Muryan
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.